Senior Vice President of $AMBA sells 3,765 shares in insider sale

In a recent transaction disclosed through an SEC filing, Chi-Hong Ju, the Senior Vice President of $AMBA, offloaded 3,765 shares of company stock on December 30, 2025, amounting to approximately $264,754. This sale constituted about 2.4% of their holdings in this class of shares, bringing their total remaining shares to 153,767 within the $AMBA stock category.

Over the past six months, $AMBA insiders have engaged in a total of 17 trades involving $AMBA stock. Among these transactions, there were no acquisitions, only sales. Chi-Hong Ju has been among the most active insiders, making 5 sales and not making any purchases, selling 17,488 shares and generating around $1,363,394 from these trades. Likewise, other executives such as Feng-Ming Wang, CEO of $AMBA, sold 9,878 shares for an estimated $746,940. Yun-Lung Chen, the VP of Business Development, disposed of 8,492 shares resulting in around $716,894. John Alexander Young, CFO of the company, sold 8,936 shares for an estimated $665,632. Chan W Lee, the Chief Operations Officer, sold 4,353 shares, netting approximately $327,449. Elizabeth M Schwarting and Leslie Kohn also divested shares for $272,608 and $178,638, respectively. Additionally, Christopher B Paisley sold 500 shares for $36,090.

Regarding institutional investments, we observed notable activity with 180 institutional investors increasing their stakes in $AMBA while 141 reduced their holdings in the most recent quarter. Some significant movements include UBS Group AG, who added a substantial 650,306 shares (an increase of 379.3%) to their holdings in Q3 2025, valued at approximately $53,663,251. Conversely, the Manufacturers Life Insurance Company removed 518,296 shares (-37.8%) from their portfolio in the same period, amounting to roughly $42,769,785. Citadel Advisors LLC, Barclays PLC, Driehaus Capital Management LLC, AXA S.A., and Baillie Gifford & Co also demonstrated notable shifts in holdings during this quarter.

In terms of financial performance, $AMBA reported revenues of $95.5 million in Q2 2026, reflecting a significant growth rate of 49.88% compared to the previous year. This upturn in revenue is a positive indicator for the company’s financial outlook. Wall Street analysts have weighed in on $AMBA, with 6 firms issuing buy ratings and no sells in recent months. Notable endorsements include a “Buy” rating from Stifel, Needham, and Rosenblatt, among others.

Price targets for $AMBA have also been set by multiple analysts. In the last 6 months, 7 analysts have published targets for the stock, with a median target price of $96.0. Notable price targets include $100.0 by Tore Svanberg, $92.0 by Vivek Arya, and $115.0 by Kevin Cassidy. These price targets serve as reference points for investors and analysts in evaluating the potential performance of $AMBA stock in the market.